Cargando…
Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes.
OBJECTIVE: To identify opportunities to reduce overuse of antibiotics for prevention of perinatal group B streptococcal (GBS) disease and management of preterm premature rupture of membranes (pPROM). METHODS: An anonymous written questionnaire was sent to each of 1031 Fellows of the American College...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784554/ https://www.ncbi.nlm.nih.gov/pubmed/16040321 http://dx.doi.org/10.1080/10647440400028144 |
_version_ | 1782132044023726080 |
---|---|
author | Glass, Nina E Schulkin, Jay Chamany, Shadi Riley, Laura E Schuchat, Anne Schrag, Stephanie |
author_facet | Glass, Nina E Schulkin, Jay Chamany, Shadi Riley, Laura E Schuchat, Anne Schrag, Stephanie |
author_sort | Glass, Nina E |
collection | PubMed |
description | OBJECTIVE: To identify opportunities to reduce overuse of antibiotics for prevention of perinatal group B streptococcal (GBS) disease and management of preterm premature rupture of membranes (pPROM). METHODS: An anonymous written questionnaire was sent to each of 1031 Fellows of the American College of Obstetricians and Gynecologists, and the responses were subjected to statistical analysis. RESULTS: Among those of the 404 respondents who saw obstetric patients in 2001, most (84%) screened for GBS colonization, and 22% of these prescribed prenatal antibiotics to try to eradicate GBS colonization. Of the 382 respondents (95%) who prescribed antibiotics for pPROM, 36% continued antibiotics for more than 7 days despite negative results from GBS cultures collected before initiation of treatment. Having more years of clinical experience (adjusted odds ratio (OR) 3.0, 95% confidence interval (CI) 1.5 to 6.2), working in a non-academic setting (adjusted OR 2.7, 95% CI 1.0 to 6.9), and prescribing antibiotics prenatally for GBS colonization (adjusted OR 2.0, 95% CI 1.1 to 3.4) were associated with prescribing prolonged antibiotics for pPROM. CONCLUSION: Prenatal antibiotic treatment for GBS colonization and prolonged antibiotic treatment for pPROM contribute to overuse of antibiotics in obstetrics. |
format | Text |
id | pubmed-1784554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
record_format | MEDLINE/PubMed |
spelling | pubmed-17845542007-02-05 Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. Glass, Nina E Schulkin, Jay Chamany, Shadi Riley, Laura E Schuchat, Anne Schrag, Stephanie Infect Dis Obstet Gynecol Research Article OBJECTIVE: To identify opportunities to reduce overuse of antibiotics for prevention of perinatal group B streptococcal (GBS) disease and management of preterm premature rupture of membranes (pPROM). METHODS: An anonymous written questionnaire was sent to each of 1031 Fellows of the American College of Obstetricians and Gynecologists, and the responses were subjected to statistical analysis. RESULTS: Among those of the 404 respondents who saw obstetric patients in 2001, most (84%) screened for GBS colonization, and 22% of these prescribed prenatal antibiotics to try to eradicate GBS colonization. Of the 382 respondents (95%) who prescribed antibiotics for pPROM, 36% continued antibiotics for more than 7 days despite negative results from GBS cultures collected before initiation of treatment. Having more years of clinical experience (adjusted odds ratio (OR) 3.0, 95% confidence interval (CI) 1.5 to 6.2), working in a non-academic setting (adjusted OR 2.7, 95% CI 1.0 to 6.9), and prescribing antibiotics prenatally for GBS colonization (adjusted OR 2.0, 95% CI 1.1 to 3.4) were associated with prescribing prolonged antibiotics for pPROM. CONCLUSION: Prenatal antibiotic treatment for GBS colonization and prolonged antibiotic treatment for pPROM contribute to overuse of antibiotics in obstetrics. 2005-03 /pmc/articles/PMC1784554/ /pubmed/16040321 http://dx.doi.org/10.1080/10647440400028144 Text en |
spellingShingle | Research Article Glass, Nina E Schulkin, Jay Chamany, Shadi Riley, Laura E Schuchat, Anne Schrag, Stephanie Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. |
title | Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. |
title_full | Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. |
title_fullStr | Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. |
title_full_unstemmed | Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. |
title_short | Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. |
title_sort | opportunities to reduce overuse of antibiotics for perinatal group b streptococcal disease prevention and management of preterm premature rupture of membranes. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784554/ https://www.ncbi.nlm.nih.gov/pubmed/16040321 http://dx.doi.org/10.1080/10647440400028144 |
work_keys_str_mv | AT glassninae opportunitiestoreduceoveruseofantibioticsforperinatalgroupbstreptococcaldiseasepreventionandmanagementofpretermprematureruptureofmembranes AT schulkinjay opportunitiestoreduceoveruseofantibioticsforperinatalgroupbstreptococcaldiseasepreventionandmanagementofpretermprematureruptureofmembranes AT chamanyshadi opportunitiestoreduceoveruseofantibioticsforperinatalgroupbstreptococcaldiseasepreventionandmanagementofpretermprematureruptureofmembranes AT rileylaurae opportunitiestoreduceoveruseofantibioticsforperinatalgroupbstreptococcaldiseasepreventionandmanagementofpretermprematureruptureofmembranes AT schuchatanne opportunitiestoreduceoveruseofantibioticsforperinatalgroupbstreptococcaldiseasepreventionandmanagementofpretermprematureruptureofmembranes AT schragstephanie opportunitiestoreduceoveruseofantibioticsforperinatalgroupbstreptococcaldiseasepreventionandmanagementofpretermprematureruptureofmembranes |